These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31201721)

  • 1. Hypoxia-Induced Resistance to Chemotherapy in Cancer.
    Minassian LM; Cotechini T; Huitema E; Graham CH
    Adv Exp Med Biol; 2019; 1136():123-139. PubMed ID: 31201721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Induced Phenotypes that Mediate Tumor Heterogeneity.
    Qian J; Rankin EB
    Adv Exp Med Biol; 2019; 1136():43-55. PubMed ID: 31201715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients.
    Devarajan N; Manjunathan R; Ganesan SK
    Crit Rev Oncol Hematol; 2021 Jun; 162():103327. PubMed ID: 33862250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting Hypoxia and Chemotherapy-Induced Cancer Cell Metastasis under a Valid Therapeutic Effect by an Assistance of Biomimetic Oxygen Delivery.
    Jiang MS; Yin XY; Qin B; Xuan SY; Yuan XL; Yin H; Zhu C; Li X; Yang J; Du YZ; Luo LH; You J
    Mol Pharm; 2019 Nov; 16(11):4530-4541. PubMed ID: 31617723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
    Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
    Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypoxic microenvironment and cancer dormancy].
    Okuyama H; Inoue M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1559-64. PubMed ID: 21996947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide.
    Barsoum IB; Hamilton TK; Li X; Cotechini T; Miles EA; Siemens DR; Graham CH
    Cancer Res; 2011 Dec; 71(24):7433-41. PubMed ID: 22006996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hypoxia in cancer therapy by regulating the tumor microenvironment.
    Jing X; Yang F; Shao C; Wei K; Xie M; Shen H; Shu Y
    Mol Cancer; 2019 Nov; 18(1):157. PubMed ID: 31711497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-mediated regulation of chemosensitivity in cancer cells.
    Matthews NE; Adams MA; Maxwell LR; Gofton TE; Graham CH
    J Natl Cancer Inst; 2001 Dec; 93(24):1879-85. PubMed ID: 11752013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and Metabolism in Metastasis.
    Zhang T; Suo C; Zheng C; Zhang H
    Adv Exp Med Biol; 2019; 1136():87-95. PubMed ID: 31201718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia Mediates Tumor Malignancy and Therapy Resistance.
    Luo W; Wang Y
    Adv Exp Med Biol; 2019; 1136():1-18. PubMed ID: 31201713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
    Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
    Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
    Yasuda H
    Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.
    Tang YA; Chen YF; Bao Y; Mahara S; Yatim SMJM; Oguz G; Lee PL; Feng M; Cai Y; Tan EY; Fong SS; Yang ZH; Lan P; Wu XJ; Yu Q
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5990-E5999. PubMed ID: 29891662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
    Barsoum IB; Smallwood CA; Siemens DR; Graham CH
    Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy.
    Hu YL; Jahangiri A; De Lay M; Aghi MK
    Autophagy; 2012 Jun; 8(6):979-81. PubMed ID: 22714142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outline of main factors of drug resistance influencing cancer therapy.
    Frączek N; Bronisz I; Pietryka M; Kępińska D; Strzała P; Mielnicka K; Korga A; Dudka J
    J Chemother; 2016 Dec; 28(6):457-464. PubMed ID: 27545330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance.
    Xuan Y; Wang YN
    J Dig Dis; 2017 Sep; 18(9):511-520. PubMed ID: 28608600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.